View in EDS HTML Full Text PDF Full Text

Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.

Saved in:
Bibliographic Details
Title: Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Authors: Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Oh C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Keskula P; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Tseng YY; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Adalsteinsson VA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Lohr JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ducar M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kryukov GV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ha G; Public Health Sciences Division and Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Rosenberg M; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Internal Medicine Program, Legacy Health, Portland, Oregon, USA., Freeman SS; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, USA., Wu X; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Takeda DY; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Loda M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pathology and Laboratory Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, USA., Wu CL; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Garraway LA; Genentech/Roche, San Francisco, California, USA., Boehm JS; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Huang FW; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Source: The Prostate [Prostate] 2022 Apr; Vol. 82 (5), pp. 584-597. Date of Electronic Publication: 2022 Jan 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35084050
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stover+EH%22">Stover EH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Oh+C%22">Oh C</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Keskula+P%22">Keskula P</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Choudhury+AD%22">Choudhury AD</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Tseng+YY%22">Tseng YY</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Adalsteinsson+VA%22">Adalsteinsson VA</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lohr+JG%22">Lohr JG</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Thorner+AR%22">Thorner AR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ducar+M%22">Ducar M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kryukov+GV%22">Kryukov GV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ha+G%22">Ha G</searchLink>; Public Health Sciences Division and Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+M%22">Rosenberg M</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Internal Medicine Program, Legacy Health, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+SS%22">Freeman SS</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Takeda+DY%22">Takeda DY</searchLink>; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Loda+M%22">Loda M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Pathology and Laboratory Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Wu+CL%22">Wu CL</searchLink>; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Taplin+ME%22">Taplin ME</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Garraway+LA%22">Garraway LA</searchLink>; Genentech/Roche, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Boehm+JS%22">Boehm JS</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Huang+FW%22">Huang FW</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228101368%22">The Prostate</searchLink> [Prostate] 2022 Apr; Vol. 82 (5), pp. 584-597. <i>Date of Electronic Publication: </i>2022 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8101368 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0045 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202704137%22">02704137 </searchLink><i>NLM ISO Abbreviation: </i>Prostate <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35084050
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pros.24305
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 584
    Titles:
      – TitleFull: Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stover EH
      – PersonEntity:
          Name:
            NameFull: Oh C
      – PersonEntity:
          Name:
            NameFull: Keskula P
      – PersonEntity:
          Name:
            NameFull: Choudhury AD
      – PersonEntity:
          Name:
            NameFull: Tseng YY
      – PersonEntity:
          Name:
            NameFull: Adalsteinsson VA
      – PersonEntity:
          Name:
            NameFull: Lohr JG
      – PersonEntity:
          Name:
            NameFull: Thorner AR
      – PersonEntity:
          Name:
            NameFull: Ducar M
      – PersonEntity:
          Name:
            NameFull: Kryukov GV
      – PersonEntity:
          Name:
            NameFull: Ha G
      – PersonEntity:
          Name:
            NameFull: Rosenberg M
      – PersonEntity:
          Name:
            NameFull: Freeman SS
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Wu X
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
      – PersonEntity:
          Name:
            NameFull: Takeda DY
      – PersonEntity:
          Name:
            NameFull: Loda M
      – PersonEntity:
          Name:
            NameFull: Wu CL
      – PersonEntity:
          Name:
            NameFull: Taplin ME
      – PersonEntity:
          Name:
            NameFull: Garraway LA
      – PersonEntity:
          Name:
            NameFull: Boehm JS
      – PersonEntity:
          Name:
            NameFull: Huang FW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0045
          Numbering:
            – Type: volume
              Value: 82
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: The Prostate
              Type: main
ResultId 1